Adiponectin protects against cardiac fibrosis but not the formation of atherosclerotic lesions in LDL receptor deficient mice

被引：0
|
作者：
Nawrocki, A. R. [1 ]
Hofmann, S. M. [2 ]
Teupser, D. [3 ]
Basford, J. E. [2 ]
Rickes, E. L. [1 ]
Tanowitz, H. B. [4 ]
Chang, C. H. [1 ]
Hui, D. Y. [2 ]
Scherer, P. E. [5 ]
机构：
[1] Merck Res Labs, Rahway, NJ USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[3] Univ Hosp Leipzig, Leipzig, Germany
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2008年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [1] Interleukin 9 treatment of LDL receptor deficient mice inhibits atherosclerotic plaque formation
    Kuiper, J
    Von der Thüsen, J
    De Vos, P
    Fekkes, ML
    Van Snick, J
    Biessen, EAI
    Van Berkel, T
    CIRCULATION, 2001, 104 (17) : 320 - 320
  • [2] Bortezomib treatment of LDL receptor deficient mice with advanced atherosclerotic lesions influences plaque composition
    Wilck, N.
    Fechner, M.
    Stangl, K.
    Stangl, V.
    Ludwig, A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 200 - 200
  • [3] CD59 protects against lesion formation in LDL receptor deficient mice: Evidence for complement activation in atherogenesis
    Yun, S.
    Leung, V.
    Botto, M.
    Haskard, D. O.
    Boyle, J. J.
    HEART, 2007, 93 (02)
  • [4] Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice
    Johansson, Fredrik
    Kramer, Farah
    Barnhart, Shelley
    Kanter, Jenny E.
    Vaisar, Tomas
    Merrill, Rachel D.
    Geng, Linda
    Oka, Kazuhiro
    Chan, Lawrence
    Chait, Alan
    Heinecke, Jay W.
    Bornfeldt, Karin E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (06) : 2082 - 2087
  • [5] Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
    Burleigh, ME
    Babaev, VR
    Oates, JA
    Harris, RC
    Gautam, S
    Riendeau, D
    Marnett, LJ
    Morrow, JD
    Fazio, S
    Linton, MF
    CIRCULATION, 2002, 105 (15) : 1816 - 1823
  • [6] Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of LDL receptor-deficient mice
    Thorp, Edward
    Kurialkose, George
    Tabas, Ira
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E62 - E62
  • [7] Adiponectin protects against angiotensin II-induced cardiac fibrosis
    Fujita, K.
    Maeda, N.
    Ohashi, K.
    Nishizawa, H.
    Nishida, M.
    Kihara, S.
    Shimomura, I.
    Funahashi, T.
    EUROPEAN HEART JOURNAL, 2006, 27 : 689 - 690
  • [8] ACTIVATION OF THE CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) DECREASES PLASMA TRIGLYCERIDES AND LDL CHOLESTEROL LEVELS AND REDUCES ATHEROSCLEROTIC LESIONS IN LDL RECEPTOR-DEFICIENT MICE
    Sberna, A. L.
    Assem, M.
    Lagrost, L.
    Masson, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [9] NADPH Oxidase 4 Protects Against Development of Endothelial Dysfunction and Atherosclerosis in LDL Receptor Deficient Mice
    Langbein, Heike
    Brunssen, Coy
    Hofmann, Anja
    Cimalla, Peter
    Bornstein, Stefan R.
    Koch, Edmund
    Morawietz, Henning
    CIRCULATION, 2015, 132
  • [10] NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice
    Langbein, Heike
    Brunssen, Coy
    Hofmann, Anja
    Cimalla, Peter
    Brux, Melanie
    Bornstein, Stefan R.
    Deussen, Andreas
    Koch, Edmund
    Morawietz, Henning
    EUROPEAN HEART JOURNAL, 2016, 37 (22) : 1753 - 1761
12345